[Correspondence] Atezolizumab and bladder cancer: facing a complex disease
Cytotoxic chemotherapy has been the first choice treatment for advanced or metastatic bladder cancer for many years, without substantial insights despite the advent of targeted therapies. Following the enthusiasm for cancer immunotherapy, several trials have investigated checkpoint inhibitors for the treatment of bladder cancer.
Source: LANCET - Category: General Medicine Authors: Carlo Cattrini, Francesco Boccardo Tags: Correspondence Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Immunotherapy